Mega Lifesciences PCL (BKK:MEGA)
Thailand flag Thailand · Delayed Price · Currency is THB
37.25
-0.25 (-0.67%)
Jul 24, 2026, 4:35 PM ICT

Mega Lifesciences PCL Stock Forecast

Stock Price Forecast

According to 7 analysts polled by S&P Global, Mega Lifesciences PCL stock has a consensus rating of "Buy" and an average price target of ฿41.14. The average 1-year stock price forecast is 10.44% higher than the current stock price, while the lowest is ฿35.00 (-6.04%) and the highest is ฿45.00 (+20.81%).

Price Target: ฿41.14 (+10.44%)
Analyst Consensus: Buy

Price Target

Chart
TargetLowAverageMedianHigh
Price฿35.00฿41.14฿42.00฿45.00
Change-6.04%+10.44%+12.75%+20.81%

Analyst Ratings

The average analyst rating for Mega Lifesciences PCL stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

Chart
RatingFeb '26Mar '26Apr '26May '26Jun '26Jul '26
Strong Buy355555
Buy000000
Hold300111
Sell111111
Strong Sell000000
Total766777

Financial Forecast

Revenue This Year
14.91B
from 14.19B
Increased by 5.07%
Revenue Next Year
15.69B
from 14.91B
Increased by 5.19%
EPS This Year
2.68
from 2.34
Increased by 14.32%
EPS Next Year
2.87
from 2.68
Increased by 7.29%
Fiscal YearFY 2021FY 2022FY 2023FY 2024FY 2025FY 2026
Period EndingDec 31, 2021Dec 31, 2022Dec 31, 2023Dec 31, 2024Dec 31, 2025Dec 31, 2026
Revenue
14.17B15.73B15.72B15.39B14.19B14.91B
Revenue Growth
12.36%10.97%-0.07%-2.10%-7.74%5.07%
Gross Profit
5.95B7.08B7.13B7.80B7.43B7.73B
Gross Margin
41.97%45.02%45.37%50.67%52.35%51.85%
Operating Income
2.18B2.72B2.94B3.41B2.95B2.99B
Net Income
1.95B2.24B1.99B2.01B1.91B2.33B
EPS
----2.342.68
EPS Growth
----1.30%14.32%
Forward PE
22.8517.7614.5211.2913.0713.93
Dividend / Share
1.381.601.601.601.601.76
Dividend Growth
-15.94%---10.21%
Free Cash Flow
1.99B1.21B1.41B2.29B2.08B2.09B
No. Analysts
-----7
EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is THB.

Revenue Forecast

Revenue202620272028
High15.4B
Avg14.9B
Low13.9B

Revenue Growth

Revenue Growth202620272028
High
8.4%
Avg
5.1%
Low
-1.8%

EPS Forecast

EPS202620272028
High2.88
Avg2.68
Low2.53

EPS Growth

EPS Growth202620272028
High
23.1%
Avg
14.3%
Low
8.1%